Sunday, 11 November 2012

USA Leads the Way in Prostate Cancer Therapy With Zytiga

The USA leads the way in using cutting edge drugs in clinical practise and Zytiga is now beeing used in 48% of prostate cancer patients in the USA who have progressed following chemotherapy. The use of Zytiga before chemotherapy is less frequent since it has not yet been FDA approved in this scenario. Zytiga has a lot of advantages over other options such as chemotherapy and its approval before chemotherapy by the FDA is being fast tracked with an announcement expected in December.

The abiraterone.blogspot website was set up to give as much information as possible to prostate cancer sufferers about abiraterone acetate (Zytiga) which is a promising new treatment for prostate cancer. This blog also strives to give up to the minute information on other new treatment options for prostate cancer and information on new drugs as they emerge. Regular updates on feeback from patients taking Zytiga are included together with news on new Zytiga combinations with promising potential. This information has been most widely viewed in the USA and the UK with viewers also coming from India and the Ukraine.

abiraterone.blogspot.com viewing statistics

United States
5239
United Kingdom
1019
Canada
453
Germany
428
Australia
345
France
327
Russia
256
India
202
Italy
160
Ukraine
107

1 comment:

  1. Prostate cancer treatment in India is the leading malignancy in men over the age of 50. It is due to the abnormal proliferation of prostatic tissue cells. It is often a slow-growing cancer and remains localized at first. Later, it may extend as it spreads to nearby tissues and organs and then metastasizes to other more distant organs (lymph nodes, bones, lungs, etc.) via the bloodstream and the lymphatic system. Preventing such a development by early screening is a major public health issue, all the more so because as life expectancy increases, so does the frequency of this cancer. Breast cancer treatment in India

    ReplyDelete